The tweet was deleted by the author.
But we saved everything 🙂.
Emergent Biosolutions announced the completion of a repurchase totaling 75 million dollars in aggregate principal amount of senior unsecured notes.
The company stated management will discuss this milestone, along with the broader progress of its transformation efforts, at upcoming investor conferences. The move comes as the company seeks to improve its financial position and market confidence through proactive management of its debt obligations.
View post on X Loading...
Emergent Biosolutions recently outlined a combined preparedness strategy, emphasizing the importance of both stockpiling and surge manufacturing to counter biological threats, as detailed in previous company communications. In addition, the company secured a Canadian government contract to supply NARCAN Nasal Spray following a competitive process, according to an earlier announcement. These developments reflect the company’s ongoing operational and commercial activities alongside its financial restructuring efforts.